Neuroprotective role of acamprosate and rasagiline in epilepsy: In silico and in vivo study
Background/Aim: Current treatments for epilepsy have only indicative relief without smashing the pathological trademarks of the disease. The unmet need is to find new therapeutic active drug candidates for effective management of epilepsy and associated neurological disorders. The present study aime...
Saved in:
| Main Authors: | Kumar Sandeep, Singh Govind, Chhikara Manisha, Shukla Sunil, Khatri Ramchander, Dar Mohammad Ovais, Lather Amit, Hooda Tanuj |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Medical Society of the Republic of Srpska, Banja Luka, University of Banja Luka. Faculty of Medicine
2025-01-01
|
| Series: | Scripta Medica |
| Subjects: | |
| Online Access: | https://scindeks-clanci.ceon.rs/data/pdf/2490-3329/2025/2490-33292503441K.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Review of acamprosate pharmacokinetics and dosing strategies
by: Lauren Steil, PharmD, et al.
Published: (2025-04-01) -
A comparative study evaluating the efficacy of naltrexone versus acamprosate as anticraving agents in alcohol use disorder
by: Samant Singh, et al.
Published: (2025-01-01) -
Neuropsychiatrie disorders in Parkinson's disease and their correction with the MAO-B inhibitor rasagiline (Azilect®)
by: M. R. Nodel
Published: (2011-09-01) -
Streamlined analytical strategy using resonance Rayleigh scattering signal amplification for nanoscale quantification of rasagiline in tablets with content assessment
by: Ahmed A. Abu-hassan
Published: (2025-07-01) -
Rasagiline for sleep disorders in patients with Parkinson’s disease: a prospective observational study
by: Schettino C, et al.
Published: (2016-09-01)